[1] |
Zoller G,Schmoll D,Mueller M,et al. Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof[P].WO,2010003624,2010-01-14. |
[2] |
Okada H,Koyanagi T,Yamada N,et al.Synthesis and anxiolytic activity of N-substituted cyclic imides (1R*,2S*3R*,4S*)-N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]--2,3-bicyclo[2.2.1] heptanedicarboximide(Tandospirone) and related compounds[J].Chem Pharm Bull,1991,39:1308. |
[3] |
Susheel JN,Mukund J,Johan B,et al.A simple Cu-catalyzed coupling approach to substituted 3-Pyridinol and 5-Pyrimidinol antioxidants[J].J Org Chem, 2008,73(23):9326. |
[4] |
Chapman D,Gabos B,Munck RM,et al.Preparation of hydantoin derivatives for use as MMP inhibitors[P].WO,2008065393,2008-06-05. |